Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MICROPAQ, MODELS 402, 404

K-Number: K021681 · 2002-07-23

ApplicantWelch Allyn Protocol, Inc.
Decision Date2002-07-23
Product CodeDRT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

MICROPAQ, MODELS 402, 404 is the device name listed in this FDA 510(k) record. The listed applicant is Welch Allyn Protocol, Inc.. It received FDA 510(k) clearance on 2002-07-23 under 510(k) number K021681. The device is classified under product code DRT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MICROPAQ, MODELS 402, 404?

MICROPAQ, MODELS 402, 404 is a medical device that received FDA 510(k) clearance on 2002-07-23. The listed applicant is Welch Allyn Protocol, Inc.. The 510(k) number is K021681.

When did MICROPAQ, MODELS 402, 404 receive FDA 510(k) clearance?

MICROPAQ, MODELS 402, 404 received FDA 510(k) clearance on 2002-07-23, under 510(k) number K021681.

Who is the listed applicant for MICROPAQ, MODELS 402, 404?

The FDA 510(k) record lists Welch Allyn Protocol, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MICROPAQ, MODELS 402, 404?

The FDA product code for MICROPAQ, MODELS 402, 404 is DRT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Welch Allyn Protocol, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K070204LINK TO ACUITY CLINICIAN NOTIFIERK063419MODIFICATION TO VSM- VITAL SIGNS MONITOR, (VSM 300 )K033378VITAL SIGNS MONITOR, PROPAQ LTK031740VSM - VITAL SIGNS MONITOR, MODEL 53000 SERIESK022453MODIFICATION TO ACUITY CENTRAL MONITORING SYSTEMK012451PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 244, 246

View all 7 devices →

Related Devices (Code: DRT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K254058DistaSense(TM) (v1)Life Detection TechnologiesK261286The Circadia C300 System (C300)Circadia Health, Inc.K252676The Circadia C300 System (C300)Circadia Health, Inc.K253388Sleepiz One+ (Model 2.5)Sleepiz AGK251364Sleepiz One+ (2.5)Sleepiz AGK234003The Circadia C200 SystemCircadia Technologies, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑